Cargando…

Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine

Dysregulated circadian functions contribute to various diseases, including cardiovascular disease. Much progress has been made on chronotherapeutic applications of drugs against cardiovascular disease (CVD); however, the direct effects of various medications on the circadian system are not well char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Chorong, Wirianto, Marvin, Kim, Eunju, Burish, Mark J., Yoo, Seung-Hee, Chen, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293187/ https://www.ncbi.nlm.nih.gov/pubmed/34206497 http://dx.doi.org/10.3390/clockssleep3030022

Ejemplares similares

Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer’s Disease Model
por: Kim, Eunju, et al.
Publicado: (2021)

The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model
por: Wirianto, Marvin, et al.
Publicado: (2022)

Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes
por: Zou, Tian, et al.
Publicado: (2022)

Circadian regulation of chemotherapy-induced peripheral neuropathic pain and the underlying transcriptomic landscape
por: Kim, Hee Kee, et al.
Publicado: (2020)

Cardiolipin Synthesis in Skeletal Muscle Is Rhythmic and Modifiable by Age and Diet
por: Nohara, Kazunari, et al.
Publicado: (2020)

The circadian E3 ligase FBXL21 regulates myoblast differentiation and sarcomere architecture via MYOZ1 ubiquitination and NFAT signaling
por: Lim, Ji Ye, et al.
Publicado: (2022)

Interactions of Rosiglitazone and Anti-Arrhythmic Drugs in Animal Model
por: Mohammed, YM, et al.
Publicado: (2012)

Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
por: von Schacky, C.
Publicado: (2012)

Hydrogen Sulfide—a potent multichannel anti-arrhythmic drug
por: Zhong, Guang-Zhen
Publicado: (2010)

New Progress in Understanding the Cellular Mechanisms of Anti-arrhythmic Drugs
por: An, Zhe, et al.
Publicado: (2018)

Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs
por: Larson, John, et al.
Publicado: (2022)

Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
por: Capucci, Alessandro, et al.
Publicado: (2023)

New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
por: Sharma, Ashish Kumar, et al.
Publicado: (2023)

Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
por: Saadeh, Khalil, et al.
Publicado: (2021)

Circadian Rhythms in Visual Responsiveness in the Behaviorally Arrhythmic Drosophila Clock Mutant Clk(Jrk)
por: Nippe, Olivia M., et al.
Publicado: (2017)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Neuronal circadian clock protein oscillations are similar in behaviourally rhythmic forager honeybees and in arrhythmic nurses
por: Fuchikawa, T., et al.
Publicado: (2017)

Propofol in ICU Settings: Understanding and Managing Anti-Arrhythmic, Pro-Arrhythmic Effects, and Propofol Infusion Syndrome
por: Paramsothy, Jananthan, et al.
Publicado: (2023)

Anti-arrhythmic properties of non-antiarrhythmic medications
por: Williams, Emmanuel Ato, et al.
Publicado: (2020)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
por: Saklani, Pradyot, et al.
Publicado: (2012)

Does Myocardial Atrophy Represent Anti-Arrhythmic Phenotype?
por: Bacova, Barbara Szeiffova, et al.
Publicado: (2022)

Targeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class
por: He, Yu, et al.
Publicado: (2023)

Are the anti-arrhythmic effects of omega-3 fatty acids due to modulation of myocardial calcium handling?
por: Sankaranarayanan, Rajiv, et al.
Publicado: (2012)

Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

The Effects of Supplementation with Omega-3 Polyunsaturated Fatty Acids on Cardiac Rhythm: Anti-Arrhythmic, Pro-Arrhythmic, Both or Neither? It Depends…
por: Rauch, Bernhard, et al.
Publicado: (2012)

Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments
por: Leybaert, Luc, et al.
Publicado: (2023)

Treatment of the arrhythmic storm
por: Grieco, Domenico, et al.
Publicado: (2019)

Risk stratifiers for arrhythmic and non-arrhythmic mortality after acute myocardial infarction
por: Gañán-Calvo, Alfonso M., et al.
Publicado: (2018)

In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation
por: Bai, Jieyun, et al.
Publicado: (2020)

Modulation of Cellular Mg(2+) Content in Cardiac Cells by α(1)-Adrenoceptor Stimulation and Anti-Arrhythmic Agents
por: Romani, Andrea M.P
Publicado: (2012)

Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds
por: Kannt, Aimo, et al.
Publicado: (2012)

Atrial Anti-Arrhythmic Effects of Heptanol in Langendorff-Perfused Mouse Hearts
por: Tse, Gary, et al.
Publicado: (2016)

Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts
por: Tse, Gary, et al.
Publicado: (2016)

Omega-3 Index and Anti-Arrhythmic Potential of Omega-3 PUFAs
por: Tribulova, Narcis, et al.
Publicado: (2017)

Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression
por: Wagner, Michael, et al.
Publicado: (2021)

Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
por: Jing, Yuling, et al.
Publicado: (2022)

Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk
por: Davies, Mark R., et al.
Publicado: (2020)

The circadian clock modulates anti-cancer properties of curcumin
por: Sarma, Ashapurna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ua42hjaft6qbbef6g7dhjqka8n